John Duke is President and Chief Executive Officer of Harvard Bioscience Inc (HBIO). The company reported total compensation of $905,208 for fiscal year 2025.
| Salary | $203,077 |
|---|---|
| Bonus | $100,000 |
| Stock awards | $598,900 |
| Option awards | $0 |
| Non-equity incentive plan | $0 |
| Pension and non-qualified deferred compensation | $0 |
| All other compensation | $3,231 |
| Total | $905,208 |
A dash means the company reported no figure in that column; 0 means it reported zero. Figures are as printed, without adjustment.
Cited to the compensation disclosure Harvard Bioscience Inc filed April 21, 2026, accession 0001171843-26-002617.
| Peer-group chief executive median | $3,616,259 |
|---|---|
| Difference from that median | $-2,711,051 |
| Percentile within the disclosed peer group | 25th |
| Peers with a disclosed figure | 11 |
Medians and percentiles are computed across the peer group Harvard Bioscience Inc discloses in its own compensation disclosure.
| Named executive officer | Role | FY2025 total |
|---|---|---|
| John Duke this page | President and Chief Executive Officer | $905,208 |
| James Green | Former Chairman, President & Chief Executive Officer | $355,823 |
| Mark Frost | Chief Financial Officer and Treasurer | $343,518 |
| Jennifer Cote | Former Chief Financial Officer and Treasurer | $123,006 |
The company's named executive officers for fiscal year 2025, and what it reported for each. See the full Harvard Bioscience Inc compensation brief.
John Duke's compensation sits inside Harvard Bioscience Inc's full executive and board picture — the peer group, pay against peers, incentive design and the board itself.